Haymaker Acquisition Corp. III (NASDAQ:HYAC) announced that its shareholders have voted to approve its combination with hormone-optimization medical practice builder Biote in a special meeting held earlier today.
Redemption numbers have not yet been disclosed. However, HYAC traded above its trust value of $10 throughout its redemption deadline Friday, May 20, and closed today at $10.06.
Nonetheless, the parties expect to close the deal on Thursday, May 26, 2022, and the common stock and warrants of the combined company are expected to commence trading on the Nasdaq Stock Exchange under the symbols “BTMD” and “BTMDW,” respectively, on Friday, May 27, 2022.
Haymaker III initially announced its $737 million combination with Biote on December 13, 2021. Irving, Texas-based Biote is a high-growth, differentiated medical practice-building business with a bioidentical hormone replacement optimization platform and complementary nutraceutical business. The company delivers an end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support.
ADVISORS
- Cooley LLP is acting as legal advisor to Biote.
- Jefferies is acting as financial and capital markets advisor to Biote.
- Truist Securities is acting as financial advisor to Biote.
- William Blair is acting as financial and capital markets advisor to Haymaker.
- Citigroup is acting as financial advisor to Haymaker.
- Truist Securities and Cantor Fitzgerald are acting as capital markets advisors to Haymaker.
- DLA Piper LLP (US) and Ellenoff Grossman & Schole LLP are acting as legal advisors to Haymaker.
Terms Tracker for the Week Ending July 3, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. We’re heading into the July 4th holiday, so we’ll keep this week’s column short and to the point. But before you head to the beach,...
Crown PropTech (OTC:CPTKW) has entered into a definitive agreement to combine with rare earth mining firm Mkango Resources (TSX-V:MKA) at a pre-money equity value of $400 million. London-based Mkango is working to commercialize a chain of rare earth mining and refining facilities in Africa and Europe. The combined company is expected to trade on the...
At the SPAC of Dawn One of the biggest sources of uncertainty in the SPAC market in recent years has been regulatory changes, but new shifts could be in its favor. SEC Chairman Paul Atkins told CNBC yesterday that the commission would review the rules for SPACs after “rather controversial” changes to the rules passed...
McKinley Acquisition Corporation (NASDAQ:MKLYU) has filed for a $150 million SPAC to hunt for an innovative target company with an experienced financial team that has dabbled in SPACs before. The new SPAC is offering investors one right to a 1/10 share in each unit with no overfunding of the trust, but it could provide a...
At the SPAC of Dawn The rain of SPACs has continued with four expected to make their debuts during today’s trading sessions after pricing their IPOs overnight. The largest of these, EQV Ventures II (NASDAQ:EVACU), even managed an upsize, making it the largest SPAC IPO since Ares II (NYSE:AACT) pulled together $450 million in 2023....